Leif Thuesen

1988–2021 年に発表

83
論文数
20,274
被引用数
76
h 指数
83
i10 指数

被引用数

Leif Thuesen の年別被引用数1980 年: 被引用 1 件1989 年: 被引用 6 件1990 年: 被引用 11 件1991 年: 被引用 6 件1992 年: 被引用 13 件1993 年: 被引用 17 件1994 年: 被引用 17 件1995 年: 被引用 24 件1996 年: 被引用 18 件1997 年: 被引用 23 件1998 年: 被引用 37 件1999 年: 被引用 45 件2000 年: 被引用 36 件2001 年: 被引用 35 件2002 年: 被引用 24 件2003 年: 被引用 40 件2004 年: 被引用 54 件2005 年: 被引用 45 件2006 年: 被引用 80 件2007 年: 被引用 69 件2008 年: 被引用 111 件2009 年: 被引用 97 件2010 年: 被引用 146 件2011 年: 被引用 170 件2012 年: 被引用 201 件2013 年: 被引用 204 件2014 年: 被引用 238 件2015 年: 被引用 169 件2016 年: 被引用 175 件2017 年: 被引用 112 件2018 年: 被引用 128 件2019 年: 被引用 300 件2020 年: 被引用 297 件2021 年: 被引用 266 件2022 年: 被引用 193 件2023 年: 被引用 136 件2024 年: 被引用 189 件2025 年: 被引用 66 件2026 年: 被引用 5 件1981〜1988 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 984 件、この内訳の 17.6%イギリス: 引用元論文 488 件、この内訳の 8.7%イタリア: 引用元論文 400 件、この内訳の 7.1%ドイツ: 引用元論文 347 件、この内訳の 6.2%オランダ: 引用元論文 335 件、この内訳の 6%デンマーク: 引用元論文 285 件、この内訳の 5.1%中国: 引用元論文 238 件、この内訳の 4.2%カナダ: 引用元論文 213 件、この内訳の 3.8%フランス: 引用元論文 205 件、この内訳の 3.7%スペイン: 引用元論文 199 件、この内訳の 3.6%オーストラリア: 引用元論文 145 件、この内訳の 2.6%スイス: 引用元論文 143 件、この内訳の 2.6%
0%17.6%その他 28.8%

分野

  • Medicine90.5%
  • Biochemistry, Genetics and Molecular Biology4.9%
  • Materials Science1.1%
  • Engineering0.9%
  • Neuroscience0.8%
  • Economics, Econometrics and Finance0.4%
  • その他1.4%

トピック

  • Coronary Interventions and Diagnostics14.2%
  • Cardiac Imaging and Diagnostics8.6%
  • Acute Myocardial Infarction Research6.5%
  • Cardiac Ischemia and Reperfusion4.4%
  • Growth Hormone and Insulin-like Growth Factors3.2%
  • Cardiac Valve Diseases and Treatments2.8%
  • その他60.3%

共著者

全論文

検索で開く
  1. Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan Ravkilde, Alisdair Ryding, Michael Rahbek Schmidt, Ingunn S. Riddervold, Henrik Toft Sørensen, Goran Stanković, Madhusudhan Varma, Ian Webb, Christian Juhl Terkelsen, John P. Greenwood, Derek M. Yellon, Hans Erik Bøtker, Anders Junker, Anne Kaltoft, Morten Madsen, Evald Høj Christiansen, Lars Jakobsen, Steen Carstensen, Steen Dalby Kristensen, Troels Thim, Karin Møller Pedersen, Mette Tidemand Korsgaard, Allan Iversen, Erik Jørgensen, Francis R. Joshi, Frants Pedersen, Hans Henrik Tilsted, Karam Alzuhairi, Kari Saunamäki, Lene Holmvang, Ole Ahlehof, Rikke Sørensen, Steffen Helqvist, B. Màrk, Anton Boel Villadsen, Bent Raungaard, Leif Thuesen, Martin Kirk Christiansen, Philip Freeman, Svend Eggert Jensen, Charlotte Schmidt Skov, Ahmed Aziz, Henrik Steen Hansen, Julia Ellert, Karsten Tange Veien, Knud Erik Pedersen, Knud Hansen, Ole Ahlehoff, Helle Cappelen, Daniel Wittrock, Poul Anders Hansen, Jens Peter Ankersen, Kim Witting Hedegaard, John Kempel, Henning Kaus, Dennis Erntgaard, Danny Mejsner Pedersen, Matthias Giebner, Troels Martin Hansen, Mina Radovanović, Maja Prodanović, Lidija Savić, Marijana Pejic, Dragan Matić, Ana Ušćumlić, Ida Subotić, Ratko Lasica, Vladan Vukcevic, Alfonso Suárez, Beatriz Samaniego ほか 487 名 - The Lancet 2019 被引用: 324

  2. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian Menown, Thor Trovik, Markku Eskola, Hannu Romppanen, Tholmas Kellerth, Lisette Okkels Jensen, Gintaras Kalinauskas, Rikard Linder, Markku O. Pentikäinen, Anders Hervold, Adrian Banning, Azfar Zaman, James Cotton, Erlend Eriksen, Sulev Margus, Lone J.H. Mogensen, Per Hostrup Nielsen, Matti Niemelä, Kari Kervinen, Jens Flensted Lassen, Keith G. Oldroyd, Geoff Berg, Simon Walsh, Colm G. Hanratty, Indulis Kumsārs, Pēteris Stradiņš, Terje K. Steigen, Ole Fröbert, Alastair N.J. Graham, Petter Cappelen Endresen, Matthias Corbascio, Olli A. Kajander, Uday Trivedi, Juha Hartikainen, Ves Anttila, David Hildick‐Smith, Leif Thuesen, Evald Høj Christiansen - The Lancet 2019 被引用: 440

  3. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colm G. Hanratty, Indulis Kumsārs, Pēteris Stradiņš, Terje K. Steigen, Ole Fröbert, Alastair N.J. Graham, Petter Cappelen Endresen, Matthias Corbascio, Olli A. Kajander, Uday Trivedi, Juha Hartikainen, Vesa Anttila, David Hildick‐Smith, Leif Thuesen, Evald Høj Christiansen - The Lancet 2016 被引用: 773

  4. Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

    著者: , , , , , , , , , , , , , , , , , - European Heart Journal 2011 被引用: 546

  5. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

    著者: , , , , , , , , , , , , , , , , , , , - The Lancet 2010 被引用: 975

  6. Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy

    著者: , , , , , , , , , , , , , , - EuroIntervention 2020 被引用: 83

  7. A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

    著者: , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2003 被引用: 1,315

  8. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

    著者: , , , , , , , , , - The Lancet 2008 被引用: 716

  9. Derivation and Validation of a Chronic Total Coronary Occlusion Intervention Procedural Success Score From the 20,000-Patient EuroCTO Registry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Hildick‐Smith - JACC: Cardiovascular Interventions 2019 被引用: 147

  10. Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis

    著者: , , , , , , , , , , , , , , , , , , - Circulation 2010 被引用: 306

  11. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

    著者: , , , , , , , , , , , , , - The Lancet 2009 被引用: 817

  12. Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis

    著者: , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2011 被引用: 525

  13. Direct intramyocardial plasmid vascular endothelial growth factor-A165gene therapy in patients with stable severe angina pectoris

    著者: , , , , , , , , , , , , , - Journal of the American College of Cardiology 2005 被引用: 463

  14. Spontaneous coronary artery dissection: A Western Denmark Heart Registry Study

    著者: , , , - Catheterization and Cardiovascular Interventions 2009 被引用: 335

  15. Randomized Comparison of Final Kissing Balloon Dilatation Versus No Final Kissing Balloon Dilatation in Patients With Coronary Bifurcation Lesions Treated With Main Vessel Stenting

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Iwar Sjögren, Stefan James, Heikki Miettinen, Jens Flensted Lassen, Leif Thuesen - Circulation 2010 被引用: 305

  16. Retrograde Recanalization of Chronic Total Occlusions in Europe

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 被引用: 239

  17. Randomized Study on Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2006 被引用: 725

  18. Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study

    著者: , , , , , , , , , , , , , , , , , , , , , - European Heart Journal 2016 被引用: 125

  19. Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2020 被引用: 76

  20. Five-Year Clinical and Functional Multislice Computed Tomography Angiographic Results After Coronary Implantation of the Fully Resorbable Polymeric Everolimus-Eluting Scaffold in Patients With De Novo Coronary Artery Disease

    著者: , , , , , , , - JACC: Cardiovascular Interventions 2013 被引用: 216

  21. Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2013 被引用: 203

  22. A prospective, randomised trial of transapical transcatheter aortic valve implantation vs. surgical aortic valve replacement in operable elderly patients with aortic stenosis: the STACCATO trial

    著者: , , , , , , , , , , , - EuroIntervention 2012 被引用: 202

  23. Long-Term Results After Simple Versus Complex Stenting of Coronary Artery Bifurcation Lesions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2013 被引用: 178

  24. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h

    著者: , , , , , , , , , , , , - European Heart Journal 2009 被引用: 106